DRUG

Silybin

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Silybin

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
STAT3 prurigo nodularis 0.208 Mid novel signal none

Clinical trials

37 registered trials for Silybin

Source: ClinicalTrials.gov